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The E8 protein of BPV-4 contributes to transformation of primary bovine cells (PalFs) by inducing anchorage-independent
growth and by down-regulating gap junction intercellular communication, likely due to its binding to 16K ductin. We show here
that, in addition, E8 confers on PalF cells the ability to grow in low serum and to escape from contact inhibition (focus
formation). E8 also transactivates an exogenous human cyclin A gene promoter, suggesting that overexpression of cyclin A
is responsible for the transformed phenotype. Mutant forms of E8 were generated to establish whether the transforming
functions of the protein could be segregated. Mutations were introduced both in the hydrophobic domain and in the
hydrophilic C-terminal “tail”, and chimeras with BPV-1 E5 were constructed. Cells expressing either wild-type E8 or mutant
forms were analyzed for their ability to grow in low serum and in suspension and to form foci. Wild-type E8 and its mutants
were also analyzed for their ability to transactivate the cyclin A promoter. We show here that the transforming functions of
E8 can be segregated and that both the hydrophilic C-terminal tail and the residue at position 17 in the hydrophobic domain
are crucial for E8 functions and for the transactivation of the cyclin A promoter. These results support the hypothesis that
the different aspects of cellular transformation brought about by E8 might be due to interaction with different cellular targets.
They suggest that E8 might function differently from BPV-1 E5 and demonstrate that the separate domains of E5 and E8 are
not functionally interchangeable. © 1999 Academic PressKey Words: BPV-4; cell transformation; E8; cyclin A.
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(INTRODUCTION
Papillomaviruses are small DNA tumour viruses with a
losed circular double-stranded genome. The genome of
apillomaviruses contains at least two genes responsi-
le for cell transformation in vitro. The main transforming
enes of human papillomavirus type 16 (HPV-16) are
epresented by the E6 and E7 open reading frames
ORFs)3 (Crook et al., 1996), with the E5 ORF assisting in
ransformation (Banks and Matlashewski, 1996) while
he two transforming genes of bovine papillomavirus
ype 4 (BPV-4) are the E7 and E8 ORFs (Jackson et al.,
996). Primary bovine fibroblasts (PalFs) transformed in
itro by BPV-4 are capable of growing independent of
ttachment to substratum. Previous work has shown that
his property is dependent on the presence and expres-
ion of the E8 ORF; cells transformed by E7 alone are not
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 0141-942-9361. E-mail: v.obrien@beatson.gla.ac.uk.
2 Present address: Department of Infectious and Tropical Diseases,
ondon School of Hygiene and Tropical Medicine, Keppel Street, Lon-
on WC1E 7HT, UK.
3 Abbreviations used: AI, anchorage-independent growth; BPV-4, bo-
ine papillomavirus type 4; GJIC, gap-junctional intercellular communi-
ation; GM, 10% serum growth medium; LS, 0.5% serum growth me-
ium; ORF, open reading frame; RT-PCR, reverse transcriptase–poly-ferase chain reaction.
385apable of anchorage-independent growth (Pennie et al.,
993). Although located at the 59 end of the early region
Jackson et al., 1991), rather than at its 39 end like the E5
RF of BPV-1 (Schiller et al., 1986) or HPV-16 (Halbert
nd Galloway, 1988), the BPV-4 E8 ORF encodes a
olypeptide that belongs to the E5 family: it is only 42
mino acids (aa) long, with a putative transmembrane
omain comprising the highly hydrophobic N-terminal 30
esidues and a hydrophilic C-terminal tail of 12 residues
Jackson et al., 1996); it is localised to the cell mem-
ranes (Pennie et al., 1993) and is expressed in the deep
ayers of early stage papillomas of the upper alimentary
anal (Anderson et al., 1997). In addition, E8 binds 16K
uctin in vitro and induces down-regulation of gap junc-
ion intercellular communication (GJIC) in transformed
alFs (Faccini et al., 1996). When expressed in an estab-
ished murine fibroblast cell line (NIH-3T3) E8 alone is
ransforming; E8-3T3 cells can grow in low serum and in
uspension, and these cellular phenotypes are associ-
ted with the ability of E8 to transactivate the cyclin A
ene promoter, to increase cyclin A protein level and
yclin A-associated kinase activity, and to inhibit the
unctions of the negative regulator of cell cycle, p27Kip1
O’Brien and Campo, 1998).
In this study we have further characterised the trans-orming activities of E8 in PalFs to establish whether, as
0042-6822/99 $30.00
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386 O’BRIEN ET AL.n NIH-3T3 cells, E8 can deregulate expression of the
yclin A gene. We show that, in addition to their ability to
row in suspension and to down-regulate GJIC, PalFs
xpressing E8 can grow in low serum and are not con-
act inhibited and that E8 transactivates the cyclin A gene
romoter in PalF cells. Using a panel of E8 mutants and
himeras constructed with BPV-1 E5, we show that the
ifferent transforming functions of E8 can be segregated
nd demonstrate that both the residue at position 17 in
he hydrophobic domain and the hydrophilic C-terminal
ail of the molecule are crucial for E8 functions.
The results obtained also suggest that E8 acts differ-
ntly from BPV-1 E5 to bring about cell transformation
nd demonstrate that the separate domains of E5 and E8
re not functionally interchangeable.
RESULTS
onstruction of E8 mutants and E8–E5 chimeras
In an attempt to segregate the different transforming
unctions of E8 and therefore to define its functional
omains, several mutations were introduced in the pre-
icted a-helical domain and in the C-terminus, and chi-
eras were constructed between BPV-4 E8 and BPV-1
5 (Fig. 1).
Studies by others have shown that binding of BPV-1 E5
o ductin requires the N-terminal hydrophobic domain
first 32 residues) and that glutamine at position 17 is
mportant for ductin interaction and for the transforming
unction of the protein (Goldstein et al., 1992; Kulke et al.,
992; Sparkowski et al., 1994, 1996). We sought to test
hether the equivalent residue, asparagine, in the E8
olypeptide of BPV-4 is also crucial for cell transforma-
ion. To define the role of the C-terminal hydrophilic tail of
8, we constructed E8T, which consists of the first 32
esidues, comprising the membrane-localised region of
8. A similar mutant form was produced for BPV-1 E5 to
reate a truncated form of this protein (E5T; residues
–31).
Two chimeras were constructed between E8 and E5 to
est the relative contribution each domain of E8 made to
ell transformation and to test whether these domains
ere functionally interchangeable between the two pep-
ides. One form, E8N–E5C, retains the N-terminus of E8
residues 1–29) but the carboxyl end is replaced by
esidues 30–44 of BPV-1 E5. The reciprocal chimera,
5N–E8C, retains the N-terminus of BPV-1 E5 (residues
–31) but the carboxyl end is replaced by residues 32–42
f BPV-4 E8 (Fig. 1).
roduction of cell lines
PalF cells can be transformed by BPV-4, or by the E7
nd E8 ORFs, only in the presence of an activated ras
ene (Jaggar et al., 1990); cell immortalisation is, how- dver, achieved only with the addition of the E6 ORF of
PV-16 (Pennie et al., 1993; Scobie et al., 1997). The cell
ines described here contain BPV-4 E7 ORF, an activated
as gene, and the HPV-16 E6 ORF introduced by gene
ransfection to generate stable transformants. If any of
hese additional plasmids was omitted from the trans-
ection protocol, no stable control cell lines were ever
btained. In addition, in no case to date have we pro-
uced a control cell line (i.e., transfected with expression
lasmids for BPV-4 E7, HPV-16 E6, and c-Ha-Ras) capa-
le of growth in low serum or in suspension (Jaggar et
l., 1990; Pennie et al., 1993; Cairney and Campo, 1995;
cobie et al., 1997).
etection of viral protein expression
Total protein extracts from representative clones,
hich were positive for viral transcripts (by RT-PCR) and
hich were fully characterised for their transformation
tatus (see below), were subjected to dot blot analysis as
escribed under Materials and Methods. The results
FIG. 1. Schematic representation of mutants and chimera used in this
tudy. For E8, the hydrophobic region is shown in black, with the
ydrophilic “tail” shown as a hatched rectangle. The single amino acid
hanges made at position 17 in E8 are illustrated using single-letter
ode. For E5, the hydrophobic and hydrophilic regions are depicted as
hite and shaded rectangles, respectively. Details of the generation
nd construction of the mutants and chimeras are given under Mate-
ials and Methods.emonstrate that E8, its mutants, E5, E5T, and E8–E5
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387TRANSFORMING FUNCTION OF BPV-4 E8 MUTANTShimeras are all expressed within PalF cells although at
omewhat different levels (Fig. 2).
utations in E8 affect anchorage-independent cell
rowth
As previously reported (Pennie et al., 1993), PalF cells
xpressing E8 can grow in suspension culture. Among
he mutants, only cells expressing E8N17S, E8N17A, and
5N–E8C were capable of anchorage-independent
rowth, with cells containing E8N17A displaying the
ighest efficiency of colony formation in methocel (Fig. 3)
nd particularly in agar where the cloning efficiency
eached 25% (not shown). E8N17Y, E8T, E8N–E5C, and
5T cells were incapable of colony formation in methocel
Fig. 3) or agar culture (not shown).
These results concur with those obtained by other
orkers for E5 and point to the importance of the residue
t position 17 (Goldstein et al., 1992; Kulke et al., 1992;
parkowski et al., 1994, 1996) and the requirement of the
FIG. 2. Detection of viral protein expression in stable PalF lines. The
ransforming potential of E8, its mutants, and the E8–E5 chimera does
ot correlate with expression levels of the proteins. Total cellular
xtracts were prepared from representative clones from each cell type
nd 2 mg of each extract was blotted onto a nitrocellulose membrane.
rotein expression was determined by immunoblotting using a mono-
lonal antibody (12CA5) against the HA epitope as described under
aterials and Methods. Vacuolar membranes preparations from yeast
lectroporated with an expression vector for HPV-16 HAE5 (Pos. ctrl.) or
n empty vector (Neg. ctrl) were a kind gift from Mr. Andrew Ashby,
eatson Institute. One microgram of total vacuolar protein was loaded
n each case.ydrophilic “tail” for the biological activity of both E5 cGreen and Loewenstein, 1987) and E8 proteins. The
esults also show that, while the C-terminal tail of E8 can
ubstitute for the tail of E5 in conferring anchorage in-
ependence, the reciprocal combination abolishes this
bility, and therefore the individual C-terminal domains
re not functionally interchangeable.
8 mutants affect cell proliferation in low serum
Although in normal medium with 10% serum (growth
edium, GM) there were no differences in growth rates
etween parental PalF cells and cells with or without E8
Fig. 4), when the serum was lowered to 0.5% (low-serum
edium, LS), only the E8 cells proved capable of contin-
ous growth (Fig. 4). Therefore, E8-expressing PalF cells
o not exit the cell cycle when deprived of serum mito-
ens and behave like E8-3T3 cells (O’Brien and Campo,
998). Cells expressing BPV-1 E5 can also grow in LS
Fig. 4b) over the 7-day period of the experiment, which,
o our knowledge, has not been demonstrated before.
E8 mutant transfectants were assayed for their growth
haracteristics in GM and in LS. Normal PalFs and all
ransfectants grew at the same rate in GM, but only
8N17A cells continued to proliferate in LS (Fig. 4a), and
here was little or no growth in cells expressing the other
utant forms, including E8N17S (Fig. 4a) and E5N–E8C
Fig. 4b), which could grow in suspension culture. Some
ell lines therefore are both capable of anchorage-inde-
endent growth and capable of proliferation in low se-
um, while others are capable of growing in suspension
ut cannot proliferate in the absence of serum mitogens.
hus the transformation phenotypes of anchorage-inde-
endent growth and of growth in low serum can be
egregated in E8N17S and E5N–E8C.
utations in E8 affect focus formation
PalF cells expressing E8 were able to form foci on a
awn of normal PalF cells (Fig. 5), showing that they can
vercome contact inhibition. Cells expressing E8N17A
ere capable of forming foci (Fig. 5), showing that, like
ells expressing wild-type E8, they have lost contact
nhibition. On the contrary, cells expressing all the other
8 mutants were incapable of forming foci. Thus, the
bility to form foci, like the ability to proliferate in the
bsence of serum mitogens, can be dissociated from the
bility to grow in suspension. Only E8N17A maintains all
he transformation potential of wild-type E8, and, surpris-
ngly, even BPV-1 E5 cannot induce loss of contact inhi-
ition in primary bovine cells.
he ability to transactivate the cyclin A promoter
orrelates with the ability to induce anchorage-
ndependent growth
We have proposed that deregulated expression of cy-
lin A and its associated kinase activities may underlie
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388 O’BRIEN ET AL.he phenotype of E8 transformed NIH-3T3 cells (O’Brien
nd Campo, 1998). In the current study, cyclin A promoter
ctivity was determined in cell lines expressing wild-type
r mutant forms of E8 to test for a correlation between
romoter activation and cell transformation brought
bout by the different E8 forms. Stable cell lines were
ransfected with a luciferase reporter gene under the
ranscriptional control of the human cyclin A promoter
FIG. 3. Anchorage-independent growth. Cells expressing E8wt, E8N
ethocel culture. Control cells were transfected with pZipneoE7, pT24, a
ector containing wild-type or mutant sequences of E8 as described in
cored by estimating the total number of colonies with a diameter grea
he bottom right-hand corner of each panel represents the number of c
ach well (1 3 105) on day 1. The experiment was performed for at le
resented in each case (final magnification, X40).Kramer et al., 1996). Under normal growth conditions txpression of wild-type E8 led to at least a 40-fold in-
rease in cyclin A promoter activity in two independent
lones when compared with control cells with no E8 (Fig.
a). A similar pattern of promoter activity was observed
n cells expressing wild-type E5 (Fig. 6a). Of the E8
utants, only E8N17A had comparable promoter trans-
ctivation activity; E8N17S and E5N–E8C transactivated
he cyclin A promoter to a lesser degree than E8 wild-
N17A, or E5N–E8C are capable of anchorage-independent growth in
16-E6, while E8 cells were transfected additionally with an expression
nd to Fig. 1. After 21 days in suspension culture, colony formation was
n 0.1 mm present in duplicate wells for each cell type. The number in
s expressed as a percentage of the total number of cells seeded into
independent clones for each cell type and a representative result is17S, E8
nd pJ4V
the lege
ter tha
olonie
ast twoype, but significantly above the levels for control cells (P
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389TRANSFORMING FUNCTION OF BPV-4 E8 MUTANTSalues for N17S and E5N–E8C , 0.01); all the other
utants were incapable of promoter transactivation (Fig.
b).
When the cells were maintained under LS conditions
or the 24-h period following transfection, promoter trans-
ctivation was sustained in the case of wild-type E8,
8N17A (Fig. 6a), E8N17S, and E5N–E8C (Fig. 6b) but not
or the other mutants. Wild-type E5 could still transacti-
ate the promoter in low serum, but reproducibly to a
esser extent than E8, suggesting a greater degree of
rowth factor dependence (Fig. 6a).
Interestingly, cells expressing E8N17S and the E5N–
8C chimera transactivate the cyclin A promoter to a
esser extent than either E8 or E5 (although to the same
xtent in high or low serum for E5N–E8C) (Fig. 6b), yet
hey fail to grow in LS (Fig. 4b). One possible explanation
or this observation is that cells expressing E8N17S and
FIG. 4. Cell proliferation in high- and low-serum medium. Growth ch
erum (LS, 0.5% serum). (a) Transformation by E8wt did not alter the g
ontinued to proliferate in LS. (b) Cells expressing truncated forms of E
n LS. Two independent clones for each cell type were maintained in L
escribed under Materials and Methods and is expressed as a growth
h after the cells were seeded) values. For normal PalF cells: n, 10%5N–E8C do proliferate in LS but proliferation is bal- mnced by cell death, resulting in little or no net population
rowth.
Very similar results were obtained in short-term trans-
ection experiments in which cells were cotransfected
ith the various forms of mutant E8 and the cyclin A
eporter both in PalF cells and in NIH-3T3 cells (data not
hown), demonstrating that the differences in cyclin A
romoter activity between control cells and those ex-
ressing E8 or its mutants were not due to differences in
he transfection efficiency between cell lines.
These results extend those obtained previously with
8-3T3 cells in which the cyclin A promoter is transacti-
ated by E8 and confirm that cyclin A promoter transac-
ivation correlates with anchorage-independent growth.
hey also show that strong cyclin A promoter transacti-
ation correlates with population growth in low serum.
The characteristics of the transformed cells are sum-
istics of cells maintained in growth medium (GM, 10% serum) and low
haracteristics of PalF cells in GM and only cells expressing E8N17A
or E5 (E5T) or E8–E5 chimera (E8N–E5C, E5N–E8C) did not proliferate
days. Cell growth was determined by dye staining (crystal violet) as
representing the fold change in cell population from day 1 (harvested
; }, 0.5% serum. For all clones: 3, , 10% serum; n, }, 0.5% serum.aracter
rowth c
8 (E8T)
S for 7
indexarised in Table 1.
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390 O’BRIEN ET AL.DISCUSSION
We have extended our analysis of the functions of
PV-4 E8 in primary bovine cells to test the transforming
bility of mutants with alterations in the hydrophobic
omain of the molecule and a truncated form of E8
onsisting of only the first 32 residues (E8T) as well as
himeras consisting of reciprocal swaps of the two do-
ains of E5 and E8 (Fig. 1).
We show that cells expressing wild-type E8 do not exit
he cell cycle after serum withdrawal, lose contact inhi-
ition, and overcome the block in late G1 imposed when
FIG. 5. Focus formation. Only cells expressing E8wt and E8N17A were
ells or E8 transfectants were seeded in 6-well plates with 25 3 103 no
fter the cells were seeded (final magnification, X40).nchorage-dependent cells are maintained in suspen-ion. PalF cells, which do not harbour E8, consistently do
ot show any of these phenotypes, despite the presence
f BPV-4 E7, HPV-16 E6, and activated ras (this study and
aggar et al., 1990; Pennie et al., 1993; Cairney and
ampo, 1995; Scobie et al., 1997). Thus, three of the
arameters of transformation, i.e., growth in suspension,
rowth in low serum, and lack of contact inhibition, are
onferred to primary cells by the E8 peptide. Despite
heir capability of growing in semisolid media, these
ransformed cells are not tumourigenic in nude mice
results not shown).
le of forming foci on a monolayer of normal PalFs. Two hundred control
alF cells. Foci were fixed and stained with a Giemsa solution 21 dayscapab
rmal PThe altered phenotypes observed for E8 mutants com-
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391TRANSFORMING FUNCTION OF BPV-4 E8 MUTANTSared with wild-type E8 cannot be ascribed to different
mounts or differential stability of the mutant forms of E8
s there is no correlation between amount of protein (Fig.
) and cell transformation or promoter transactivation
Table 1). For instance the nontransforming mutants
8N17Y, E8T, and E8N–E5C are expressed at higher
evels than the hypertransforming mutant E8N17A (Fig.
). This identifies mutant protein function and not differ-
nces in expression level as the cause of the different
henotypes observed in this study (Table 1).
FIG. 6. Transactivation of the human cyclin A promoter. (a) The trans
f the reporter plasmid pwt929 into independent clones of stable trans
ellular protein content. Values represent the mean of duplicate sampl
b) Scaled-up representation of control, N17S, N17Y, E8T, E8N–E5C, a
alues. *Statistically significant differences versus control cells in bot
alculated by Student’s t test.
T
Transformation Characteristics
Cell type AI Growth LS Growth
Control (no E8) 2 2
E8 wild type 1 1
E8N17S 1 2
E8N17Y 2 2
E8N17A 11 1
E8T 2 2
E8N–E5C 2 2
E5N–E8C 1 2
BPV-1 E5 1 1
E5T 2 2
Note. AI, anchorage-independent; LS, growth in low serum. The p
etermined. E5T was tested in transient transfection experiments where it faiIn BPV-1 E5, the glutamine residue at position 17 has
een shown to be critical for cell transformation (Kulke et
l., 1992; Sparkowski et al., 1994, 1996). This appears to
e the case also for the asparagine residue in the same
osition in BPV-4 E8. Mutation of this single amino acid
rings about profound changes in the activity of the
rotein. Thus mutation to a tyrosine residue completely
bolishes the transforming capability of E8, while muta-
ion to an alanine residue creates a “hypertransforming”
olecule with increased ability to induce anchorage-
nal activity of the cyclin A promoter was determined after transfection
s for each cell type. Luciferase activity is given after normalization on
experiments performed at least twice. Bar represents standard error.
–E8C to illustrate statistical significance of promoter transactivation
and low serum. P , 0.01 for N17S, E5N–E8C; others P . 0.1. P was
Expressing E8 or Its Mutants
Focus formation
Cyclin A promoter
GM LS
2 2 2
1 11111 1111
2 11 1
2 2 2
1 1111 11
2 2 2
2 2 2
2 11 11
2 11111 111
2 nd nd
ns represent the extent of expression of the characteristic. nd, notcriptio
fectant
es from
nd E5N
h highABLE 1
of Cells
lus sig
led to transactivate the cyclin A promoter in either high or low serum.
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392 O’BRIEN ET AL.ndependent growth, and mutation to a serine residue
eads to an intermediate state that allows only the main-
enance of the anchorage-independent phenotype.
learly, although the role of the residue at position 17 is
nknown, this residue is critical for the integrity of E8
iological functions. Interestingly, a E5 mutant contain-
ng, like E8, an asparagine residue at position 17 is not
ransforming in mouse fibroblast lines (Sparkowski et al.,
994). In addition, in contrast to BPV-1 E5, this residue
oes not appear to be crucial for E8–ductin interactions,
t least in vitro (manuscript in preparation).
Another critical domain of E8 is its C-terminal hydro-
hilic tail. The C-terminus truncated mutant, containing
nly the putative transmembrane portion of the molecule,
s transformation defective. Confirmation that the C-ter-
inal tail of E8 is essential for PalF transformation is
rovided by the chimera E8N–E5C, consisting of the
ydrophobic portion of E8 and the hydrophilic tail of E5,
hich is incapable of inducing a transformed phenotype
n these cells. Both the membrane domain of E8T and the
8N–E5C chimera may adopt an altered nonfunctional
onformation or have a different cellular distribution than
ild-type E8. These points still await elucidation. The
unctional failure of E8N–E5C also points to the non-
quivalence of the domains of E8 and E5; while the tail of
5 cannot substitute for the tail of E8, the reciprocal
xchange leads to a chimeric molecule still retaining the
bility to induce anchorage-independent growth. Indeed,
espite the overall amino acid and structural homology
f E8 and E5, there are differences between the two
ransforming proteins in the PalF system: E8, but not E5,
llows cells to escape from contact inhibition and E5
ppears to be more dependent on serum mitogens for
ransactivation of the cyclin A promoter. This suggests
hat these small papillomavirus proteins may have over-
apping but different mechanisms of achieving cell trans-
ormation.
The use of the mutant forms of E8 has allowed the
egregation of its several transforming functions. Thus
he ability to induce substrate-independent growth can
e separated from the ability to form foci or to prevent
ell cycle exit in low serum. Focus formation and growth
n low serum still cosegregate in the E8 mutants, but,
nterestingly, not in wild-type E5, which, as noted above,
annot induce escape from contact inhibition, while al-
owing growth in low serum. This was an unexpected
bservation. However, E5, but not E8, can induce foci in
IH-3T3 cells (V. O’Brien, unpublished observations),
hus illustrating cell-type-specific differences in the
ransforming potential of these small papillomavirus pro-
eins.
In PalF cells, as in NIH-3T3 cells (O’Brien and Campo,
998), E8 expression promotes transcriptional transacti-
ation of a heterologous cyclin A promoter under condi-
ions where cyclin A transcription is normally diminished Or is not detectable in control cells. E8 mutants that can
ransactivate the cyclin A promoter confer to PalF cells
he ability to grow in suspension, and mutants that
trongly transactivate the promoter permit population
rowth in low serum (Table 1). These observations sup-
ort our hypothesis that E8-mediated cell transformation
s, at least in part, due to the ability of the viral protein to
eregulate cyclin A expression and associated kinase
ctivities (O’Brien and Campo, 1998). This hypothesis can
e refined in light of the results described here to sug-
est that a threshold of cyclin A promoter transactivation
orrelates with cell transformation; this threshold is well
xceeded by E8wt, E8N17A, and E5wt (Fig. 6a) and just
xceeded by E8N17S and E5N–E8C (Fig. 6b). Further
ork to test this hypothesis is under way in NIH-3T3
ells, a system that requires only the introduction of E8
or cell transformation and where the reagents required
o carry out these studies are readily available.
Overall, the results demonstrate that the multiple
ransforming functions of E8 can be segregated, which
ikely reflects the complex interactions of the domains of
8 with different cellular targets.
MATERIALS AND METHODS
lasmids
pZipneoHAE8, encoding G418 resistance and carrying
he E8 ORF containing a sequence encoding the 11-
esidue HA-1 epitope of the influenza virus 59 to the E8
equence, has been reported previously (Faccini et al.,
996). pZipneoE7, expressing the E7 ORF, and pT24, a
UC13-derived plasmid containing the 6.6-kb activated
uman c-Ha-ras oncogene, have also been described
reviously (Pennie et al., 1993). pZipneoHAE8 served as
he template for mutant construction. E8 mutants con-
aining single amino acid substitutions at residue 17, a
-terminus truncated form of E8 (E8T; N1-32), in which a
remature stop codon has been introduced at residue
3, and a C-terminus truncated form of BPV-1 E5 (E5T;
1-31), with a premature stop codon introduced at posi-
ion 32, were produced by site-directed mutagenesis
sing the Altered Sites kit (Promega), following the man-
facturer’s instructions. For the construction of E8–E5
himeras, site-directed mutagenesis was used to create
n AccI site in BPV-4 E8 at a position similar to that
ccurring in BPV-1 E5. Exchange of the 39 ends of the E5
nd E8 ORFs was achieved using standard cloning pro-
edures to give two chimeras: E8N–E5C, containing an
RF encoding residues 1–29 of E8 and residues 30–44
f E5, and E5N–E8C, encoding residues 1–31 of E5 and
esidues 32–42 of E8.
pJ4V16-E6 was a gift from Dr. L. Crawford (Department
f Pathology, University of Cambridge). This plasmid con-
truct is a pBR322 derivative containing the HPV-16 E6
RF.
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393TRANSFORMING FUNCTION OF BPV-4 E8 MUTANTSpwt929 is a luciferase reporter plasmid for the human
yclin A promoter. This plasmid construct was a gift from
r. William Fahl, University of Wisconsin (Kramer et al.,
996).
ell culture and stable transfection
Primary bovine fibroblasts were derived from the foetal
alate (PalFs) as described previously (Jarrett et al.,
990) and used at passages 2–8. Cells were routinely
ultured in Dulbecco’s modified Eagle’s medium (DMEM)
ontaining 10% foetal calf serum (growth medium) and
ubcultured to maintain subconfluent monolayers. Cells
5 3 105) were transfected with a range of plasmids
sing a cationic lipid (DOTAP; Boehringer Mannheim)
ollowing the manufacturer’s instructions. Each reaction
ontained 5 mg of the indicated expression plasmids and
onicated salmon sperm DNA (Sigma) to bring the total
mount of DNA to 20 mg. After 16–18 h cells were
ashed twice with warm medium, transfectants were
elected in medium containing 500 mg/ml G418 for 21–28
ays, and G418-resistant colonies were then picked and
xpanded. Two independent clones were used for each
ell type in the transformation experiments. All transfec-
ants were routinely maintained in GM supplemented
ith 500 mg/ml G418.
etection of viral protein expression in PalF cell lines
Cells were lysed in near-boiling SDS–PAGE sample
uffer lacking bromophenol blue and dithiothreitol, son-
cated, and clarified by centrifugation at 13,000g for 5 min
t 4°C then adjusted to 2 mg/ml total protein in each
ase. Equal amounts of protein (2 mg) were blotted onto
nitrocellulose membrane (ECL Hybond, Amersham) in
Bio-Dot microfiltration apparatus (Bio-Rad). The mem-
rane was then blocked in PBS containing 5% nonfat
ilk (Marvel) for 1 h at room temperature and incubated
ith a dilution (1:1000) of a monoclonal antibody that
ecognises the HA epitope (12CA5, Boehringer Mann-
eim) in 5% nonfat milk in 10 mM maleic acid, 15 mM
aCl, pH 7.5 (antibody dilution buffer), overnight (16–20
) at 4°C. The membrane was washed three times (5 min
ach) in 50 mM NaCl, 10 mM Tris–HCl, 0.05% Tween 20,
H 7.5, and then incubated with HRP-conjugated anti-
ouse antibody (Amersham; 1:5000) in antibody dilution
uffer for 45 min at room temperature. After washing the
embrane as described above, antibody binding was
isualised by chemiluminescence (ECL, Amersham).
rotein loading was confirmed by staining blots with a
onoclonal antibody to a-tubulin (results not shown).
nchorage-independent growth
Cells (1 3 105) were added to 15 ml of methocel
edium (Pennie et al., 1993) and the mix was plated inacterial petri dishes. Cells, tested in duplicate, were leftt 37°C for 12 days before being scored and photo-
raphed.
ocus formation assay
Two hundred cells of each clone were mixed with
5,000 parental PalF cells. The cell suspension was
lated in 6-well plates, in triplicate. Medium was replen-
shed twice weekly and after 20–25 days the cells were
ashed with PBS, fixed in methanol, stained with 10%
iemsa solution, and photographed.
etermination of cell growth rate in high- and low-
erum cultures
PalF cells and derived transfectant cells were seeded
n 96-well tissue culture plates, in triplicate, at 3000
ells/well in 200 ml of GM. After 5 h of incubation, during
hich time the cells attached to the bottom of each well,
riplicate wells for each cell type were left undisturbed or
ere switched to DMEM with 0.5% serum (LS). Cells
ere washed with prewarmed (37°C) PBS before the
ddition of 100 ml of a solution of 0.1% crystal violet in
0% methanol. The plate was placed overnight at room
emperature. Crystal violet solution was removed and
ells were washed extensively in water and then air-
ried. Dye was solubilised in 100 ml of 1% SDS, 0.2 M
aOH solution and the absorbance of the solubilised
ye was determined immediately at 590 nm using an
utomated microplate reader (Dynatech MR7000).
yclin A promoter reporter assays
Cells were seeded at 20,000 cells/ml in GM in each
ell of 6-well plates, 5 ml/well, the day before transfec-
ion with the luciferase reporter plasmid pwt929 by the
tandard calcium phosphate method. After 16–18 h, cells
ere washed twice with 2 ml PBS and incubated in LS or
M for a further 24 h before harvesting. Luciferase ac-
ivity in the supernatants was determined as described
reviously (O’Brien and Campo, 1998) and activity was
ormalised for protein content determined using the BCA
ssay (Pierce Chemical Co.).
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